Physician

Devin Burr, D.O.

According to 2025 Medicare claims, Devin Burr, D.O. (NPI: 1417331869) practices dermatology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is DMB MEDICAL PLLC (NPI: 1093597890; TIN: 88-4307458) and primary practice location at 84097-5480.

Burr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 750 traditional Medicare patients, billed 6,604 HCPCS/CPT codes, and received $317,373 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 1,005 prescription claims across 317 beneficiaries totaling $426,748 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 93 records totaling $1,213. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $20,176 to $317,373. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,148 to $426,748. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$159K$317K2019 Medicare payment: $20,176 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $55,075 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $75,711 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $90,880 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $207,519 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $317,373 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201946200$20,176
2020115793$55,075
20212171,475$75,711
20222631,642$90,880
20234113,525$207,519
20247506,604$317,373

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$213K$427K2017 Drug cost: $2,148 (USD; Tot_Drug_Cst)2018 Drug cost: $236 (USD; Tot_Drug_Cst)2019 Drug cost: $2,265 (USD; Tot_Drug_Cst)2020 Drug cost: $8,634 (USD; Tot_Drug_Cst)2021 Drug cost: $9,185 (USD; Tot_Drug_Cst)2022 Drug cost: $147,515 (USD; Tot_Drug_Cst)2023 Drug cost: $254,253 (USD; Tot_Drug_Cst)2024 Drug cost: $426,748 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20173147$2,148
2018N/R12$236
201959101$2,265
2020121280$8,634
2021158398$9,185
2022179442$147,515
2023267797$254,253
20243171,005$426,748

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths287359$104
11102Biopsy of related skin growth, first growth208241$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more281362$57
17000Destruction of precancer skin growth, 1 growth450606$37
17003Destruction of precancer skin growth, 2-14 growths3923,156$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab16616$89,441
Triamcinolone AcetonideTriamcinolone Acetonide1575,628$2,178
KetoconazoleKetoconazole943,435$1,612
Betamethasone DipropionateBetamethasone Dipropionate311,162$1,231
Clobetasol PropionateClobetasol Propionate411,220$1,075

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.93$1,213ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Devin Burr, D.O.?

Tedicare shows public-source Medicare data for Devin Burr, D.O. (NPI 1417331869), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Devin Burr, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Devin Burr, D.O.?

Devin Burr, D.O. is linked to DMB MEDICAL PLLC (billing NPI 1093597890) in the available physician profile data.

Does Devin Burr, D.O. have Open Payments data?

Devin Burr, D.O. has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.